The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
Authors
Keywords
-
Journal
Transplant Immunology
Volume 79, Issue -, Pages 101858
Publisher
Elsevier BV
Online
2023-05-24
DOI
10.1016/j.trim.2023.101858
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
- (2022) Carlo Scognamiglio Renner Araujo et al. ANNALS OF THE RHEUMATIC DISEASES
- Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
- (2022) Amanthi Nadira Arumahandi de Silva et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
- (2022) Rebecca H Haberman et al. Lancet Rheumatology
- COVID-19 vaccination and antirheumatic therapy
- (2021) Jack Arnold et al. RHEUMATOLOGY
- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies
- (2021) Serre-Yu Wong et al. GASTROENTEROLOGY
- Psoriasis
- (2021) Christopher E M Griffiths et al. LANCET
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
- (2021) Serena Bugatti et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
- (2021) Mark W Tenforde et al. CLINICAL INFECTIOUS DISEASES
- BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel
- (2021) Tal Brosh-Nissimov et al. CLINICAL MICROBIOLOGY AND INFECTION
- Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
- (2021) Mark M. Painter et al. IMMUNITY
- Recent advances in antibody‐based immunotherapy strategies for COVID‐19
- (2021) Abdolreza Esmaeilzadeh et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
- (2021) Laura Boekel et al. Lancet Rheumatology
- Humoral Response to SARS-CoV-2 Vaccine of a Patient Receiving Methotrexate Treatment and Implications for the Need of Monitoring
- (2021) Krzysztof Lukaszuk et al. Vaccines
- Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Methotrexate and its mechanisms of action in inflammatory arthritis
- (2020) Bruce N. Cronstein et al. Nature Reviews Rheumatology
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- The global, regional, and national burden of psoriasis in 195 countries and territories, 1990–2017: A systematic analysis from the Global Burden of Disease Study 2017
- (2020) Sino Mehrmal et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
- (2020) ANNALS OF THE RHEUMATIC DISEASES
- Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
- (2019) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Global, regional and national burden of rheumatoid arthritis 1990–2017: a systematic analysis of the Global Burden of Disease study 2017
- (2019) Saeid Safiri et al. ANNALS OF THE RHEUMATIC DISEASES
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Sudabeh Alatab et al. Lancet Gastroenterology & Hepatology
- Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Z.Z.N. Yiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
- (2017) Meliha C. Kapetanovic et al. VACCINE
- The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
- (2015) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
- (2009) Janet E. McElhaney et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started